ENOMERS

Beyond the Sting Redefining the Future of Bio-Active Science & Global Biotech Leadership

We do not merely harvest elements; we unlock the ultimate future of global science.

Born from the strategic synergy of Avand Kashef Tasnim (AKT) and premier international alliances, Venomers stands as the undisputed global pioneer in bio-active innovation. Operating the world’s largest 22-hectare biotech infrastructure, we have mastered the full value chain of pristine, native scorpion venom. By bridging the gap between nature’s deepest bio-mechanics and elite pharmaceutical research, we empower next-generation oncology drug discovery and ultra-premium dermocosmetics.

Bio-Value Chain Pipeline

From native species to high-value biotech derivatives. A sterile, vertically integrated biological ecosystem.

Biological Infrastructure & Professional Academy

Controlling the biotechnology ecosystem starts with foundation and knowledge. We operate the world's largest scorpion breeding facility spanning over 22 hectares with a capacity of over 4 million scorpions. By training professional breeders and establishing standardized biological infrastructures, we guarantee the safety, ethics, and sustainability of our parent colonies.

22+ Hectares 4M+ Scorpion Capacity Professional Certifications

Closed-Loop Bio-Nutrition (Dedicated Mealworm Production)

The bio-activity and purity of venom rely directly on the health of the species. To ensure the highest quality and precise nutritional health, we maintain a dedicated in-house mealworm (Tenebrio molitor) production unit. This closed-loop feeding system eliminates external biological contamination and guarantees consistent venom profiles.

100% Organic Diet Zero External Contamination Strict Quality Control

In-House Electronic Systems & Smart IoT Engineering

To achieve complete operational autonomy, we design and manufacture our proprietary electronic hardware in-house—ranging from advanced, non-destructive venom extraction devices to high-precision IoT data loggers. By engineering our own data loggers, we maintain absolute control over the microclimate of our massive breeding halls and continuously monitor the critical cold chain of our bioactive venoms, guaranteeing molecular stability from the moment of extraction to final delivery.

In-House Hardware Manufacturing Breeding Hall Climate Control End-to-End Cold Chain Loggers

Sterile Venom Extraction & Ultra-Low Temperature Preservation

Venom extraction is performed under strict laboratory supervision and fully sterile conditions to guarantee maximum purity. The liquid venom is immediately processed and preserved at -80°C to secure long-term stability and bioactive integrity. Upon request, we leverage state-of-the-art lyophilization for freeze-dried formats.

-80°C Cryopreservation Fully Sterile Labs Lyophilization Ready

Bioactive Molecular Analysis & Certified Quality Assurance

Every single batch of our products is accompanied by official laboratory analyses and verified certificates. Through scientific collaboration with world-class experts, we identify, purify, and characterize specific venom-derived proteins, peptides, and amino acid sequences to meet global pharmaceutical standards.

HPLC & Molecular Profiling Official Certificates Peer-Reviewed R&D

High-Value Biotech Derivatives & Market-Ready Formulations

We transform raw biological resources into scientifically validated commercial products. Our portfolio includes premium pure venoms, therapeutic scorpion oil, and advanced bioactive compounds for cosmetics, hydrating creams, and medical research, positioning us at the forefront of global biotechnology.

Scorpion Oil & Pure Venoms Cosmeceutical Integration Global B2B Supply

Scientific Advisory & Executive Board

The global minds driving the Venomers bio-active revolution.

Javad Atashi

Founder & CEO of Venomers Holding

Strategic Biotechnology Leadership & International Business Development

Leading the world’s largest biological and scorpion breeding infrastructure with an annual processing capacity of 12 liters of high-purity venom.

Managing a biological supply chain with a breeding capacity of over 4 million scorpions across 12 native species.
Establishing international joint ventures (JV) and technology transfer agreements with Oman, Germany, and Turkey.
Founder of the Venomers Professional Academy, dedicated to developing standardized and stress-free venom extraction protocols.
Co-author of peer-reviewed international publications in prestigious journals including Nature (Scientific Reports, 2025) and Toxins (MDPI, 2022).

Dr. Mohammad Hossein Morowvat

Distinguished Scientist in Pharmaceutical Biotech

Pharmaceutical Biotechnology, Protein Engineering, and Algal Bioproducts

Distinguished scientist with a proven track record of leading major projects in recombinant protein production, monoclonal antibodies, and cosmeceuticals.

Ph.D. in Pharmaceutical Biotechnology from Shahid Beheshti University of Medical Sciences.
Published over 110 peer-reviewed scientific papers, registered 2 national patents, and submitted 128 gene sequences to the NCBI database.
Recipient of numerous prestigious scientific awards, including the Razi Festival and the NIMAD Elite Young Researchers Grant.
Member of the National Elites Foundation and the Medical Council of Iran.

Dr. med. Thomas Georg Hans Flietner

Scientific Advisor & EU Strategic Partner

Plastic & Reconstructive Surgery, General Surgery, Biotech & Medical Devices

Senior Consultant Surgeon, Scientific Advisor, and EU Strategic Partner for Avand Kashef Tasnim with over 40 years of distinguished clinical, surgical, academic, and international leadership experience.

Dr. med. (magna cum laude) and Board Certified Specialist in Plastic & Reconstructive Surgery and General Surgery.
Senior Scientific Advisor & EU Strategic Partner for Avand Kashef Tasnim (AKT) & Founder/Medical Director of Collegium Clinic.
Over 40 years of experience in severe burn management, microsurgery, humanitarian reconstructive surgery, and medical devices export.
Full Member of DGPRÄC (German Association of Plastic Surgeons) and BDC (Professional Association of German Surgeons).

Dr. Hossein Barahoei

Senior Scorpion Biosystematist

Scorpion Taxonomy, Molecular Phylogenetics, and Morphology

Leading scientific authority in the identification, screening, and biological authentication of scorpion species for pharmaceutical venom extraction.

Ph.D. in Animal Biosystematics from Ferdowsi University of Mashhad.
Research Assistant Professor at the University of Zabol and leader of specialized biosystematics field campaigns.
Aligning biological data of scorpion species for therapeutic peptide synthesis in downstream drug development phases.
Extensive publication of research papers investigating the molecular and morphological diversity of the Buthidae lineage.

Dr. Adel Abdollahnia

Venom Proteomics Expert

Venomics, Advanced Mass Spectrometry, and Molecular Drug Design

International researcher and developer of advanced protocols for the analysis and isolation of bioactive peptides from complex venoms.

Recipient of an international research fellowship in molecular pharmacology from the Medical University of Vienna, Austria.
Development of specialized protocols for mass spectrometry instruments, including MALDI-TOF and LC-ESI-QTOF-MS/MS.
Proficient in bioinformatics tools and molecular modeling software for venoms, such as PEAKS Studio Xpro and Schrödinger.
Proven track record of major research at the Medicinal Plants Research Institute of Shahid Beheshti University.

Dr. Fatemeh Sabet Sarvestani

Researcher in Regenerative Medicine

Biomaterials Development, Stem Cell Biology, and Novel Biomedical Products

Focused on translating complex laboratory findings into therapeutic and clinical products for tissue regeneration and the management of diabetic complications.

Ph.D. in Molecular Medicine from the Transplant Research Center of Shiraz University of Medical Sciences.
Doctor of Veterinary Medicine (DVM) degree from Shiraz University.
Expert in advanced cell culture, molecular diagnostics, and the development of skin-regenerating healthcare products.
Leading projects focused on translating preclinical studies into human therapeutic platforms.

Dr. Mohammad Zaree

Senior R&D & Embedded Systems Engineer

Embedded Systems Design, Laboratory Instrumentation, and Digital Signal Processing (DSP)

Interdisciplinary researcher and innovator with over 15 years of specialized R&D experience in digital electronics and high-precision laboratory instrumentation design.

Ph.D. in Digital Electronics and M.Sc. in Applied Electronics; specialist in hardware architecture, FPGA, and embedded systems development.
Senior R&D Engineer at Avand Kashef Tasnim; lead designer of high-precision industrial sampling equipment, cold chain monitoring systems, and data loggers.
Holder of a national patent for a digital AC/DC current analyzer with a remarkable accuracy of 100 femtoamperes.
Author of peer-reviewed international ISI scientific papers focused on high-precision instrumentation and advanced industrial electronics integration.

Ahmadreza Sadeghi

Senior Software Engineer

Data Science, Computational Modeling, Optimization Algorithms & Web Platform Architecture

Chief architect of Venomers' next-generation digital infrastructure and cloud platforms, specializing in computational bioinformatics modeling, big data processing, and scalable enterprise web systems.

Developed and deployed intelligent data-mining models and optimization algorithms to monitor biological telemetry and mega-farm logistics.
Chief designer and architect of the company’s digital ecosystem and corporate web platforms, specializing in full-stack architecture and secure API protocols.
Holds a Professional Certificate in Computer Science for Web Programming and Artificial Intelligence from Harvard University (HarvardX).
Academic lecturer and research collaborator in interdisciplinary software engineering, computational algorithms, and database systems.

Our Partners & Collaborators

Pioneering the peptide biotechnology industry and commercializing advanced, scorpion-derived products demands a powerful ecosystem of international strategic alliances anchored by world-class academic expertise. Our global network seamlessly integrates cross-border economic entities with prominent scientific institutions:

Global Expansion & Commercial Partners

Strategic & Infrastructure Partner in Turkey (AKREP İLAÇ)

A deep commercial and technological alliance driven by direct equity participation and the co-development of our landmark project within Turkey’s Advanced Technology Development Zone (DEPARK). This partnership focuses on the transfer of proprietary biotechnology formulations and the co-ownership of international brands in specialized scorpion oil lines and premium dermocosmetics—all fully aligned with European Union regulatory standards.

Industrial Base Expansion in the Kingdom of Oman

A cross-border mega-project executed through a multi-year roadmap. It encompasses comprehensive technology transfer, the design and outfitting of modern, automated breeding facilities, and the localization of venom extraction processes to secure the supply chain across the GCC region and target international markets.

Scientific & Research Partners

International Academic Collaborators:

Justus Liebig University Giessen (Germany)

Strategic international collaboration focusing on advanced molecular analysis and comprehensive proteomic profiling of natural venoms.

Biotechnology & Research Centers (Austria)

Technical knowledge exchange aimed at the discovery, characterization, and in vitro evaluation of novel bioactive compounds.

National Academic & Medical Partners:

Shiraz University of Medical Sciences (Biotechnology Incubator)

Our primary technology host, accelerator, and core partner for preclinical evaluations regarding the cellular effects of venom-derived compounds.

Shahid Beheshti University (Medicinal Plants Research Institute)

Collaboration on the therapeutic evaluation of bioproducts and high-precision proteomic analysis projects.

University of Zabol & Hormozgan University of Medical Sciences

Established research agreements dedicated to the joint development of functional biological products for pharmaceutical and dermatological applications.

This interconnected network allows us to seamlessly bridge proven, evidence-based academic science with world-class commercial infrastructure. As a result, our final products reach global consumers, clinical researchers, and industrial sectors at the highest international standards, fully compliant with stringent GMP protocols.

Our Infrastructure

Two geostrategically positioned operational hubs form the backbone of our vertically integrated supply chain—bridging advanced pharmaceutical R&D with large-scale biological production.

Faculty of Pharmacy at Shiraz University of Medical Sciences — Venomers Global R&D Hub

Global Headquarters & R&D Center

SUMS Biotechnology Incubator

The scientific core and intellectual engine of the holding, embedded within the Faculty of Pharmacy at Shiraz University of Medical Sciences. Powered by advanced proteomics infrastructures, bioanalytical validation, and automated FPLC protein purification systems, this hub orchestrates the R&D and discovery phase of proprietary biotech and cosmic peptides.

Scorpion Biological Mega-Farm

Larestan Infrastructure

The world's largest biological scorpion breeding and reproduction facility, spanning over 22 hectares with a capacity exceeding 4,000,000 scorpions across diverse native species. Engineered with a dedicated mealworm production mega-unit for biological nutrition, sterile venom extraction cleanrooms, and a proprietary smart IoT environmental telemetry network that continuously guarantees cold chain compliance.